deferoxamine has been researched along with Communicable Diseases in 2 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Communicable Diseases: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To review the adverse effects and risks of deferoxamine for the treatment of iron poisoning." | 8.79 | Risks of parenteral deferoxamine for acute iron poisoning. ( Howland, MA, 1996) |
| "To review the adverse effects and risks of deferoxamine for the treatment of iron poisoning." | 4.79 | Risks of parenteral deferoxamine for acute iron poisoning. ( Howland, MA, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Williams, A | 1 |
| Meyer, D | 1 |
| Howland, MA | 1 |
2 reviews available for deferoxamine and Communicable Diseases
| Article | Year |
|---|---|
Desferrioxamine as immunomodulatory agent during microorganism infection.
Topics: Animals; Communicable Diseases; Cytokines; Deferoxamine; Humans; Immunologic Factors; Iron Chelating | 2009 |
Risks of parenteral deferoxamine for acute iron poisoning.
Topics: Administration, Oral; Antidotes; Communicable Diseases; Deferoxamine; Ear Diseases; Eye Diseases; Hu | 1996 |